Report Overview

The US Crohns disease market size stood at around USD 7.4 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

The US Crohns Disease Market is expected to witness significant growth due to rising awareness about inflammatory bowel and Crohns diseases. Crohns diseases trigger due to bacterial, environmental and immune factors. Higher preference for symptomatic therapeutic, better treatment of inflammatory bowel diseases, arrival of enhanced drugs, and healthier investments in R&D programs are the major factors contributing to the growth of the Crohns Disease market. Lack of early diagnosis techniques and high cost of treatment are the major factor restricting the growth of market



Market Drivers

The US market is expected to dominate the global Crohns disease market due to the increasing prevalence of Crohn's disease and growing per capita healthcare expenditure in the region.

According to the Crohns Colitis Foundation, over 0.8 million Americans currently have Crohns disease. In this region, urbanization is a significant factor to the increasing prevalence of Crohn's disease. The incidence of CD has been attributed to the result of the westernization of lifestyles, such as changes in diet, smoking, and differences in exposure to sunlight, pollution, and industrial chemicals.